
Procter & Gamble Co (NYSE:PG, XETRA:PRG) is expected to show stronger sales momentum when it reports fiscal first-quarter 2027 results before the market opens on October 22, according to UBS. The brokerage kept its Buy rating and $172 price target, saying improving top-line trends should be enough to drive outperformance.










